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Abstract
Introduction: Insulin gene VNTR was associated with polycystic ovary syndrome (PCOS) in some studies but not in others. This could 
be due to the heterogeneity of the definition of PCOS and/or the use of inappropriate gene mapping strategies.
Material and methods: In this investigation, the association of VNTR with PCOS was explored in a population of women from Central 
Europe (377 cases and 105 controls) in whom PCOS was diagnosed according to Rotterdam criteria. Seven SNPs: rs3842756 (G/A), rs3842755 
(G/T), rs3842754 (C/T), rs3842753 (A/C), rs3842752 (C/T), rs3842748 (G/C), and rs689 (T/A) were genotyped in a portion of the population 
(160 cases and 95 controls) by sequencing or by SSO-PCR. Analysis of linkage disequilibrium (LD) pattern allowed selecting three tagSNPs 
(rs3842754, rs3842748, and rs689), which were genotyped in the rest of the population by KASPar.
Results: Six haplotypes were reconstructed, among which three (h1, h2 and h6) were more frequent. Statistical analysis allowed observa-
tion of the association of the SNP rs3842748, through its GC genotype, with obesity in PCOS (P = 0.049; OR CI95% 1,59 [1.00–2.51]) and 
in classical PCOS (YPCOS) (P = 0.010), as well as the correlation of the SNP rs689 and the pair of haplotypes h1/h1 with higher levels of 
testosteronaemia in the PCOS group, although this was at the limit of significance (P = 0.054)
Conclusion: These results are in accordance with some studies in literature and highlight the role of insulin gene VNTR in complex 
metabolic disorders. (Endokrynol Pol 2015; 66 (3): 198–206)
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Streszczenie
Wstęp. W niektórych badaniach, zmienna liczba powtórzeń tandemowych (VNTR) genu insuliny była związana z zespołem policystycz-
nych jajników (PCOS), lecz w innych taki związek nie występował. Mogło tak być z powodu heterogeniczności definicji PCOS i/lub 
stosowania nieprawidłowych strategii mapowania genów.
Materiał i metody: W niniejszym badaniu, związek VNTR z PCOS zbadano w populacji kobiet pochodzących z Europy Środkowej (377 
przypadków chorobowych oraz 105 osób kontrolnych), u których zdiagnozowano PCOS według kryteriów rotterdamskich. Siedem poli-
morfizmów pojedynczego nukleotydu (SNP): rs3842756 (G/A), rs3842755 (G/T), rs3842754 (C/T), rs3842753 (A/C), rs3842752 (C/T), rs3842748 
(G/C), oraz rs689 (T/A) wytypowano w części populacji (160 przypadków chorobowych i 95 osób kontrolnych) poprzez sekwencjonowanie 
lub SSO-PCR. Analiza wzoru niezrównoważenia sprzężeń (LD) pozwoliła na selekcję trzech SNP znacznikowych (tagSNP) (rs3842754, 
rs3842748 i rs689), które wyselekcjonowano w pozostałej części populacji metodą KASPar.
Wyniki: Sześć haplotypów odtworzono, z których 3 (h1, h2 i h6) występowały częściej. Analiza statystyczna pozwoliła na obserwację 
związku SNP rs3842748, poprzez genotyp GC, z otyłością w PCOS (P = 0,049; OR CI 95% 1,59 [1,00–2,51]) i klasycznym PCOS (YPCOS) 
(P = 0,010), jak również korelacji SNP rs689 i pary haplotypów h1/h1 z wyższym stężeniem testosteronemii w grupie PCOS, chociaż 
wynik ten znajdował się na granicy istotności (P = 0,054).
Wnioski: Powyższe wyniki są zgodne z niektórymi badaniami w piśmiennictwie i podkreślają role VNTR genu insuliny w złożonych 
zaburzeniach metabolicznych. (Endokrynol Pol 2015; 66 (3): 198–206)
Słowa kluczowe: minisatelita; gen; PCOS; insulina; SNP
This work was supported by: Recurrent budget from University of Montpellier (France); Recurrent budget from University Medicine 
and Pharmacy “Carol Davila” in Bucharest (Romania). This work was also sustained by the grant MEDIGENE FP7-279171 of European 
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studies (GWAS) screening hundred of thousands 
of SNPs associated the locus of insulin gene VNTR 
with prostate cancer [25], through the SNP rs7127900, 
but failed, to our knowledge, to find any association 
with metabolic disorders, which updates the ques-
tion concerning loci found associated with complex 
disorders through the candidate gene approach and 
missed by GWAS studies.
In this context, the aim of the present study was 
to investigate the association of insulin gene VNTR 
with PCOS in a population of women from Central 
Europe based on haplotyping strategy. Our final aim 
was to compare the power of haplotypes with that 
of SNPs taken alone and to get a preliminary idea 
about the best strategy for studying the genetics of 
complex disorders. 
Material and methods
Population recruitment
The study was approved by the Ethical Committee 
of The University of Bucharest (Romania), according 
to Helsinki Declaration (revised in 1983) and after in-
formed consent. Participants in the investigation were 
not related and were of Caucasian origin (Region of 
Walachia, Romania). Type 1 genetic design [26] com-
paring PCOS with control lean healthy women was 
applied. Note that no patient in this study had diabetes.
Control population
The control population was composed of 105 lean 
healthy women recruited in the Obstetrics and Gy-
naecology Department of the University of Bucharest. 
These women had a normal reproductive status, regular 
menses, proven fertility (at least one child), and no 
clinical or biochemical hyperandrogenism.
PCOS population
A total of 377 women with PCOS were included. Diag-
nosis of PCOS was established according to Rotterdam 
criteria [27]. Individuals with Cushing Syndrome, 
non-classical deficiency of adrenal 21-hydroxylase, 
hyperprolactinaemia, and androgens secreting neo-
plasms were excluded from the study. PCOS women 
were stratified as lean (BMI < 30 kg/m²) and obese 
(BMI > 30 kg/m²). PCOS with more insulin resistance 
and Acanthosis nigricans (HA-IR-AN syndrome) was 
distinguished from classical PCOS (Y-PCOS), as pre-
viously reported [28].
Clinical and biochemical characteristics
The women were given a standard diet. Then, oral 
glucose tolerance test (OGTT) was applied to the group 
of PCOS women. IGT and impaired fasting glucose 
Introduction
Polycystic ovary syndrome (PCOS) is a complex disease 
that affects 5 to 10% of women in reproductive age [1, 2]. 
PCOS is characterised by hyperandrogenism and 
chronic anovulation [2, 3], but also by a high frequency 
of insulin resistance, impaired glucose tolerance (IGT), 
insulin secretion abnormalities, and type 2 diabetes 
(T2D) [2, 4, 5].
The insulin gene minisatellite (VNTR, variable num-
ber of tandem repeats) was associated with PCOS [6, 7], al-
though this has not been confirmed in other studies [8, 9]. 
VNTR of insulin gene was also associated with type 1 
diabetes (T1D) [10, 11], T2D [12], childhood obesity [13], 
insulin sensitivity, insulin secretion in children [14], and 
insulin levels in plasma [15].
Insulin gene VNTR is localised 596 bp upstream 
from the transcription initiation site. It regulates the ex-
pression of both insulin and IGF-2 (insulin-like growth 
factor-2) genes [16, 17]. Insulin gene VNTR is formed by 
a repetition of a consensus sequence of 14 to 15 bp. It 
involves two principle classes in the non-African popu-
lations: a short and a long one called class I and class III, 
respectively [10, 18]. VNTR of class I was associated with 
a higher risk of T1D [10] while VNTR of class III was 
associated with an increased risk of PCOS [6] and T2D 
[12]. The SNP (single nucleotide polymorphism) rs689 
located upstream from exon 2 of the insulin gene was 
strongly associated with T1D [11]. This polymorphism 
has two alleles: A and T, in strong linkage disequilibrium 
(LD) with VNTR of class I and III, respectively, allowing 
for the use of this SNP as a surrogate of the minisatel-
lite in association studies. However, it was reported 
that this polymorphism has a role in the regulation of 
insulin gene expression through an alternative splicing 
process [19], although the impact of the phenomenon is 
minor [20]. On the other hand, a high LD was observed 
between haplotypes of some SNPs in the insulin gene 
region and subclasses of the insulin gene VNTR in 
non-African populations [21]. Note that the subclasses 
IC and ID (VNTR of class I) were differently correlated 
with fasting insulin in childhood obesity in the French 
population [22], while the two other haplotypes in LD 
with the two subclasses IIIA and IIIB of the minisatellite 
were differently associated with the protective effect 
against T1D [23].
The role of the insulin gene and its minisatellite 
in PCOS and in the metabolic pattern of the disease 
remains controversial. This controversy was accen-
tuated after the study carried out by Bouatia-Naji 
et al., who showed no familial association of insulin 
gene VNTR with childhood obesity in 1023 families 
or with fasting insulin levels or birth weight in obese 
children [24]. Moreover, genome-wide association 
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(IFG) were defined according to American Diabetes 
Association (ADA) criteria [29]. Insulin resistance was 
assessed by HOMAIR (homeostatic model assessment insu-
lin resistance) index, and insulin secretion by HOMA-β 
(homeostatic model assessment β-cell function). Note that 
HOMAIR (mmol/L) = (fasting glucose X fasting insu-
lin)/22.5 while HOMA-β (mmol/L) = (fasting insulin X 
20)/(fasting glucose — 3.5).
Measurement of lipid parameters and godanotro-
pins (FSH and LH) in the plasma was carried out in the 
Department of Endocrinology in Bucharest. Clinical 
and biochemical characteristics of the population are 
shown in Table I.
Note that the first portion of the population (160 
cases and 90 controls) was used for genotyping seven 
genetic markers (SNPs). The aim was to determine the 
LD pattern between these SNPs and select tag-SNPs to 
be genotyped in the rest of the population.
Genetic exploration
Description of the explored genomic region
The insulin gene (MIM: 176730) is located in the locus 
11p15.5, downstream from its minisatellite (VNTR) by 
about 400 bp. The gene extends on 1431 bp and contains 
three exons. The region involving SNPs considered in 
the present study starts from the end of the first intron 
and extends beyond the 3’UTR side of the gene.
Genotyping of SNPs
All SNPs were genotyped in a portion of the popula-
tion (160 women with PCOS and 95 controls) by clas-
sical sequencing or SSO-PCR. An overview of these 
techniques was previously reported [30]. Primers and 
PCR steps used for each SNP are reported in Table IIA. 
In the rest of the population (377 women with PCOS 
and 105 controls), only SNPs rs3842754, rs3842748, and 
rs689 were genotyped by KASPar technology [31], using 
primers and following the amplification steps reported 
in Table IIb.
Data and statistical analysis
The LD pattern of the explored genomic region was 
determined by Haploview 3.31 [32]. Haplotype re-
construction was carried out by PHASE 2.1 [33] and 
cladistics analysis by Arlequin 2.000 [34]. Concerning 
clinical and biochemical characteristics of the popula-
tion, continuous variables (expressed as median [25% 
percentile — 75% percentile]) were analysed using 
non-parametrical tests. Significance when comparing 
between continuous variables in phenotypic groups 
was calculated by Mann-Whitney non-parametrical 
test (significance was attested for P < 0.05), while 
Fisher ’s exact test was used for comparing between 
percentages (significance was attested for P(X2) 
< 0.05). The distribution of continuous parameters in 
the population was checked by Kolmogorov-Smirnov 
test. A non-normal distribution was attested for 
P < 0.05. Variation of SNPs was expressed as allelic 
frequency (q) or prevalence (%) of their genotypes, 
while variation of haplotypes was expressed as their 
prevalence or the prevalence of pairs of haplotypes. 
The genetic association was determined by logistic 
regression using StatView 5.0 and SAS (Abascus 
Concepts, Berkeley, CA), as previously described 
[35]. Results were expressed as nominal P, odds ratio 
(OR), and 95% confidence interval (CI). Genotype- 
-phenotype correlations were assessed by Mann-
Whitney test. The power of the case-control study 
was calculated by Sampsize software (http://sampsize.
sourceforge.net/iface/s3.html).
Results
Phenotypic data
The explored population involved 482 women (377 
with PCOS and 105 controls). Among PCOS women, 
148 were obese and 71 were with severe insulin resist-
ance (hyperandrogenism-insulin resistance-Acanthosis 
nigricans “HA-IR-AN” syndrome) (Table 1). Women 
with PCOS had higher BMI (P < 0.0001), higher LH/ 
/FSH (P < 0.0001), higher testosteronaemia (P < 0.0001), 
higher fasting insulin (P < 0.0001), and higher insulin 
secretion (HOMAβ) (P < 0.0001). On the other hand, 
Acanthosis nigricans was more often observed in PCOS 
obese women than in PCOS lean (P < 0.0001). Moreo-
ver, PCOS obese women had higher fasting insulin than 
lean PCOS (P < 0.0001), were more insulin resistant 
(P < 0.0001), and had higher insulin secretion (HOMAβ: 
P < 0.0001). HA-IR-AN women had higher BMI than 
YPCOS (P < 0.0001) and were more insulin resistant 
(P < 0.0001) and secretory (P < 0.0095). Note that no 
patient in this study had diabetes.
Note that the portion of the population where the 
seven SNPs were genotyped (160 women with PCOS 
and 95 controls) displayed the following character-
istics: the median age of the PCOS group (25 and 75 
percentiles) was 24.0 years (21.0–28.0) while it was 
32.5 years (27.0 - 37.0) (P < 0.0001) for controls. PCOS 
women had higher BMI: 30.00 kg/m2 (24.12–34.4) vs. 
22.00 (20.00 – 23.85) (P < 0.0001) and were more insulin 
resistant: HOMAIR: 3.31 (1.86–5.58) vs. 1.25 (0.90–1.68) 
(P < 0.0001). The test for the distribution of continuous 
parameters showed non-normal distribution of many 
parameters such as BMI (P < 0.0001), HOMA-β index, 
and plasmatic testosterone, while dehydroepiandros-
terone sulphate (DHEAS) plasmatic levels displayed 
normal distribution (P). 
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Genotypic data
Polymorphism analysis in part of the population (160 
women with PCOS and 95 controls) showed that SNPs 
rs3842756, rs3842755, rs3842754, rs3842753, rs3842752, 
rs3842748, and rs689 were in high LD according to the 
D’ index (Fig. 1). However, three groups of SNPs were 
observed according to the level of high LD between 
them (according to r2 LD index): group 1 (rs3842756, 
rs3842755, rs3842754, rs3842752), group 2 (rs3842753 
and rs689), and group 3 (rs3842748). Thus, we con-
sidered SNPs rs3842754, rs689, and rs3842748 to be 
representative for the first, the second, and the third 
group, respectively. These SNPs were genotyped in the 
rest of the population. Frequencies of SNPs rs3842754, 
rs3842748, and rs689 in the control group were 0.17, 0.83, 
and 0.75, respectively, which are very close to their fre-
quencies in other Caucasian populations (http://www.
ncbi.nlm.nih.gov/snp/). Reconstruction of haplotypes 
was done using the three SNPs allowed observing six 
haplotypes: h1 (CCA), h2 (CCT), h3 (CGA), h4 (CGT), 
h5 (TCA), and h6 (TGT) (Table III). It appeared that the 
three haplotypes h1, h2, and h3 were frequent while the 
Table II. Techniques and primers used for genotyping SNPs: A. rs3842756, rs3842755, rs3842754, rs3842753, and rs3842752 in 
the first portion of the population (160 women with PCOS and 95 controls); B. rs3842754, rs3842748, and rs689 in the rest of 
the population (the whole population included 377 women with PCOS and 105 controls)
Tabela 2. Techniki i primery zastosowane w procesie genotypowania SNP: A. rs3842756, rs3842755, rs3842754, rs3842753 i 
rs3842752 w pierwszej części populacji (160 kobiet cierpiących na PCOS i 95 osób kontrolnych); B. rs3842754, rs3842748 i 
rs689 w pozostałej części populacji (cała populacja wynosiła 377 kobiet z PCOS i 105 kobiet w grupie kontrolnej)
A.
SNPs Technique of genotyping Used primers Steps of PCR
rs3842756
rs3842755
rs3842754
rs3842753
rs3842752
Sequencing (GoldStart® 
DNA polymerase)
Forward primer 5’-ACT GTG TCT CCC TGA CTG TGT 
C-3’
Reverse primer 5’- GAC TCC AAG AGT CCA GAG 
CTA C-3’
95°C (8’), 35 cycles of [94°C (15’’), 60,8°C (10’’), 
72°C (45’’)], and 72°C (6’)
rs3842748 Sequence specific 
oligonucleotide-PCR 
(SSO-PCR)
Common reverse primer 5’-CTC ACG GCA GCT CCA 
TAG TC-3’
Forward primers 5’-AGA GGG AGG GTC ACC CAC 
AC-3’ and 5’-AGA GGG AGG GTC ACC CAC AG-3’
95°C (8’), 35 cycles of [94°C (15’’), 56.6°C (10’’), 
72°C (45’’)], and 72°C (6’)
rs689 sequencing (GoldStart® 
DNA polymerase)
Forward primer 5’-CTT GGG TGT GTA GAA GAA 
GC-3’
Reverse primer 5’-AGC AGG TCT GTT CCA AGG-3’
95°C (8’), 35 cycles of [94°C (15’’), 56,6°C (10’’), 
72°C (45’’)], and 72°C (6’)
rs689 Sequence specific 
oligonucleotide-PCR 
(SSO-PCR)
Forward primers 5’-CAG AAG GAC AGT GAT CTG 
GGT-3’ and 5’-CAG AAG GAC AGT GAT CTG GGA-3’
Reverse primer 5’-TCC AGG ACA GGC TGC ATC 
AG-3’
95°C (8’), 35 cycles of [94°C (15’’), 56,6°C (10’’), 
72°C (45’’)], and 72°C (6’)
B.
SNPs Technique of genotyping Used primers Steps of PCR
rs3842754 KASPar technology Forward specific primers: 5’-CCC AAA GCG GCC 
ATG CCT GTT-3’ and 5’-CCA AAG CGG CCA TGC 
CTG TC-3’
Common reverse primer: 5’-CCA TAC TGG ACC CTG 
AGC CAC A-3’
94°C (15’), 10 cycles of [94°C (20’’), 61°C (1’), drop 
annealing temperature 0.6°C per cycle to reach 
55°C in the last cycle], 26 cycles of [94°C (10’’), 
55°C (1’)], and recycling [94°C (20’’), 57°C (1’)] as 
many times as required
rs3842748 KASPar technology Allele specific primers 5’-GCC TGT AGG TCC ACA 
CCC AC-3’ and 5’-GCC TGT AGG TCC ACA CCC 
AG-3’
Common reverse one 5’-GTT AGA GGG AGG GTC 
ACC CAC A-3’
94°C (15’), 10 cycles of [94°C (20’’), 61°C (1’), drop 
annealing temperature 0.6°C per cycle to reach 
55°C in the last cycle], 26 cycles of [94°C (10’’), 
55°C (1’)], and recycling [94°C (20’’), 57°C (1’)] as 
many times as required
rs689 KASPar technology Allele specific primers 5’-GCC TCA GCC CTG CCT 
GTC A-3’ and 5’-GCC TCA GCC CTG CCT GTC T-3’
Common reverse primer 5’-CAT CCA CAG GGC CAT 
GGC AGA A-3’
94°C (15’), 10 cycles of [94°C (20’’), 61°C (1’), drop 
annealing temperature 0.6°C per cycle to reach 
55°C in the last cycle], 26 cycles of [94°C (10’’), 
55°C (1’)], and recycling [94°C (20’’), 57°C (1’)] as 
many times as required
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three others were rare. When we started from the root 
of the cladogram (h4), the mutation of rs3842754 from 
C to T allowed us to observe h6 (surrogate of VNTR of 
subclass IIIA), while mutation of rs3842748 from G to 
C allowed us to reach the rest of the cladogram (Fig. 2). 
Mutation of SNP rs689 from T to A led to h1 (VNTR of 
class I). This data is in accordance with literature [21].
Figure 1. Linkage disequilibrium (LD) pattern (estimated by 
D’ index) in the region of insulin gene between rs3842756 and 
rs689, in the female population (cases and controls) from Central 
Europe. The numbers in red squares indicate the D’ index (%). 
The squares without numbers indicate a perfect LD (D’ = 100% 
or 1) between the corresponding SNPs 
Rycina 1. Wzór niezrównoważenia sprzężeń (LD) (wyliczony 
przez indeks D’) w regionie genu insuliny między rs3842756 
i rs689 u populacji kobiet (przypadki chorobowe i osoby kontrolne) 
z Europy Centralnej. Liczby w czerwonych kwadratach oznaczają 
indeks D’ (%). Kwadraty bez liczb oznaczają idealne LD (D’ = 100% 
lub 1) między odpowiednimi SNP
Table III. List of haplotypes resulting from combination of SNPs rs3842754, rs3842748, and rs689 in the population of women 
(cases and controls) from Central Europe used in the study, and their prevalence. Mutated alleles of SNPs in each haplotype 
are underlined. Ancestral alleles are those of chimpanzee (Pan troglodytes)
Tabela III. Lista haplotypów otrzymanych z kombinacji SNP: rs3842754, rs3842748 i rs689 w populacji kobiet (przypadki 
chorobowe i osoby kontrolne) z Europy Centralnej, wykorzystane w badaniu, a także ich prewalencja. Zmutowane allele SNP 
zostały podkreślone w każdym z haplotypów. Allele ancestralne należą do szympansów (Pan troglodytes)
Haplotype rs3842754 
(C/T)
rs3842748 
(G/C)
rs689 
(T/A)
Number  
of alleles
Prevalence 
(%)
h1 C C A 693 71.89
h2 C C T 96 9.96
h3 C G A 3 0.31
h4 C G T 3 0.31
h5 T C A 3 0.31
h6 T G T 166 17.22
Figure 2. Phylogenetic (cladistics) affiliation of SNPs rs3842754, 
rs3842748, and rs689 illustrating the historical evolution of 
haplotype diversity in the female population (cases and controls) 
from Central Europe used in the study. The ancestral (root) 
haplotype (CGT) is h4. The haplotype h6 (TGT) is due to the 
mutation (C → T) of the SNP rs3842754. The haplotype h2 (CCT) 
derived from h4 after the mutation (G → C) of the SNP rs3842748, 
while the haplotype h1 (CCA) is due to the mutation of both rs689 
(T → A) and rs3842748 (G → C) 
Rycina 2. Związek filogenetyczny (kladystyka) SNP: rs3842754, 
rs3842748 i rs689 ilustrujący ewolucję różnorodności haplotypów 
w populacji kobiet (przypadki chorobowe i osoby kontrolne) z Europy 
Centralnej, wykorzystane w badaniu. Haplotyp ancestralny (CGT) 
to h4. Haplotyp h6 (TGT) powstał w wyniku mutacji (C → T) SNP 
rs3842754. Haplotyp h2 (CCT) uzyskano z h4 po mutacji (G → C) 
SNP rs3842748, podczas gdy haplotyp h1 (CCA) powstał w wyniku 
mutacji zarówno rs689 (T → A), jak i rs3842748 (G → C)
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We observed that the genotype GC of rs3842748 
was associated with the obese phenotype in PCOS 
(P = 0.049) and in the classical PCOS (YPCOS) group 
(P = 0.010) (Table IV). The association with obesity in 
YPCOS remained after adjustment for age. The pair 
of haplotypes h1/h6 were associated with the obese 
phenotype in classical PCOS (P = 0.009) and remained 
also after adjustment for age. The data of association 
with obesity was supported by the correlation between 
the pair of haplotypes h1/h6 and higher BMI in the 
YPCOS group (h1/h6: P = 0.048, 28.5 ± 0.9 vs. 26.3 ± 0.4) 
and a trend for correlation between the GC genotype 
of rs3842748 and higher levels of BMI in the YPCOS 
group (P = 0.077).
SNPs and their haplotypes were also correlated with 
plasmatic levels of androgens in PCOS group. Indeed, 
we observed the correlation of rs689, through its AA 
genotype and the pair of haplotypes h1/h1, with higher 
levels of testosteronaemia, but this was at the limit of 
significance (rs689 (AA): P = 0.054, 87.1 ± 4.2 ng/dL vs. 
74.9 ± 2.0 ng/dL; haplotype h1/h1: P = 0.054, 86.9 ± 4.1 
ng/dL vs. 74.9 ± 2.0 ng/dL). Moreover, rs3842754 and 
rs3842748, through their alleles C and C, respectively, 
were correlated with lower plasmatic levels of DHEAS 
in PCOS women with obesity (rs3842754 (C): P = 0.041, 
260.7 ± 16.9 µg/dL vs. 432.9 ± 61.6; rs3842748 (C): P = 
0.041, 260.7 ± 16.9 vs. 432.9 ± 61.6) (Fig. 3). Note that 
the power of the study concerning each positive genetic 
association is reported in Table IV.
Discussion and conclusions
PCOS is a complex disorder characterised by abnormali-
ties related to reproduction and others with metabolism 
Table IV. Resume of positive genetic association between polymorphisms in the insulin gene and obesity in PCOS (all 
PCOS group or only women with classical PCOS “YPCOS”) as well as the power of the study for each genetic association. 
Assumptions for calculating the power are: the size of control and cases group, the odd ratio, the percentage of the genotype 
among the control group, the ratio control group/cases group, and the alpha risk = 5%. The genetic association was attested 
as significant for P < 0.05
Tabela IV. Podsumowanie pozytywnego związku genetycznego między polimorfizmami w genie insuliny i otyłością w PCOS 
(cała grupa z PCOS lub tylko kobiety z klasycznym PCOS “YPCOS”), jak również siłą badania dla każdego powiązania 
genetycznego. Założenia dla wyliczenia siły są następujące: wielkość grupy kontrolnej i grupy przypadków chorobowych, 
współczynnik szans, procent genotypu w grupie kontrolnej, stosunek grupy kontrolnej do grupy przypadków chorobowych 
oraz współczynnik alfa = 5%. Związek genetyczny został potwierdzony jako istotny dla P < 0,05
The genetic 
association
The phenotype 
associated with
Odds ratio 
95% CI
p Control group Case group % of the genotype among 
the control group
Power the 
association (%)
GC genotype of 
rs3842748
Obesity in YPCOS 2.01  
(1.18–3.42)
0.010 YPCOS and lean  
(n = 212)
YPCOS with obesity  
(n = 93)
22.27 72.85
The pair of 
haplotypes h1/h6
Obesity in YPCOS 2.08 
(1.20–3.61)
0.009 YPCOS and lean  
(n = 212)
YPCOS with obesity  
(n = 93)
19.34 73.95
GC genotype of 
rs3842748
Obesity in YPCOS 1.59 
(1.00–2.51)
0.049 PCOS and lean  
(n = 228)
PCOS with obesity  
(n = 148)
23.50 51.19
Figure 3. Graphic comparing dehydroepiandrosterone sulphate 
(DHEAS) levels between individuals carrying the allele C of the 
SNP rs3842748 and the others. DHEAS levels are indicated by mean 
± standard error. The significance of the difference is determined by 
the Mann-Whitney test. P is considered significant when < 0.05 
Rycina 3. Graficzne porównanie stężenia siarczanu dehy-
droepiandrosteronu (DHEAS) pomiędzy nosicielami allela C SNP 
rs3842748 i innymi. Stężenie DHEAS oznaczono jako średnią 
± błąd standardowy. Istotność różnicy statystycznejustalana jest 
na podstawie testu Manna-Whitneya. P uznano za istotne dla 
wartości P < 0,05
and glucose homeostasis, including insulin secretion ab-
normalities. Indeed, women with PCOS were reported 
as having a decrease in insulin secretion [5]. Insulin 
gene minisatellite (VNTR), which was implicated in 
the regulation of insulin gene expression, is a poten-
tial candidate in PCOS. Different investigations were 
carried out and gave controversial results [6–9]. Some 
of these studies focused on VNTR itself while others 
used rs689 as a surrogate since this SNP has two alleles 
in high LD with VNTR of Class I and III, respectively, 
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in non-African populations. Moreover, studies used 
different definitions for diagnosing PCOS. One could 
speculate that the heterogeneity between investigations 
is the cause of controversy concerning the association 
of insulin gene VNTR with PCOS.
In order to get more insight we investigated the 
association of insulin gene VNTR with PCOS using 
dense mapping of the genome and reconstruction of 
haplotypes. The Rotterdam Conference criteria [27] 
were used for diagnosing PCOS, giving an accurate 
and precise definition of the disease. All this accuracy 
was aimed to give an ideal context for determining the 
relation between the minisatellite and PCOS.
The SNPs taken into account in this study have been 
demonstrated to combine into haplotypes in high LD 
with classes and subclasses of VNTR, which allowed 
them to be used as surrogates. Their genotyping was 
carried-out in a portion of the population, with the aim 
of determining the LD pattern and selecting from them 
those that tag the region (tagSNP = representative of 
a group of SNPs in high LD). Three tagSNPs were then 
selected and genotyped in the rest of the population, 
including rs689. In addition to its ability to mimic the 
variation of the insulin gene minisatellite, this SNP was 
implicated in the regulation of insulin gene expression 
through an alternative splicing process [19, 20].
We observed the correlation of the genotype AA 
of rs689 and the pair of haplotypes h1/h1 with higher 
levels of testosteronaemia in PCOS and with lower 
plasmatic levels of DHEAS in PCOS with obesity, which 
highlights once again the close relation between the 
reproductive and the metabolic components in PCOS, 
as already reported many times in literature (Diamanti-
Kandarakis. 2008).
Moreover, the correlation between the gene and 
lower plasmatic levels of DHEAS in our study is in-
teresting and in accordance with literature. Indeed, 
previous studies reported negative correlation between 
DHEAS levels in plasma and HOMAIR index (reflects 
fasting insulin) in PCOS [37], as well as high levels of 
DHEAS being correlated with lower insulin levels and 
more favourable metabolic and cardiovascular pa-
rameters [38]. Our finding may give more insight into 
understanding the genetic background that controls 
variations of DHEAS.
Moreover, the genotypes GC of rs3842748 and h1/h6 
(corresponding to the genotype I/III of VNTR) were as-
sociated with obesity and correlated with higher BMI in 
PCOS (especially PCOS with lower insulin resistance), 
which represents a novelty in our study. Note that this 
genotype has been previously associated in T1D with 
glutamic acid decarboxylase antibodies (GADA) [39] but 
never with T2D, PCOS, or obesity. At the same time, the 
minisatellite of class III, widely associated in literature, 
with PCOS and T2D [6, 12] displayed weak results 
in our investigation. Perhaps the situation is more 
complicated than expected. Indeed, locus involving 
insulin gene VNTR involves IGF-2 (MIM: 147470) and 
tyrosine hydroxylase (MIM: 191290) genes. These two 
genes were associated, as well as the minisatellite, with 
metabolic parameters [40]. Combining the variation of 
these three genes may ameliorate the genetic study 
and determine subgroups of VNTR of class III other 
than IIIA and IIIB (determined by our haplotypes). One 
could speculate that the heterozygote genotype I/III 
of VNTR in our population encompasses a subgroup 
of VNTR class III related to obesity. The association of 
VNTR I/III with obesity could be due also to VNTR 
of class I. Here also the context seems to be complex. 
Indeed, Le Stunff et al. observed an excess of paternal 
transmission of VNTR of class I to obese children [13] 
and other studies attested to the role of genetic imprint-
ing occurring in the INS-IGF2 locus at the age of onset of 
monogenic diabetes caused by INS gene mutations [41]. 
Future studies concerning this locus should take into 
account this phenomenon.
Criticism could be addressed concerning the size of 
the explored population, especially in the context of cur-
rent genetic association studies exploiting populations 
of thousands of individuals, with the aim of getting 
statistical power. Such studies may display weakness at 
the phenotypic level in the sense that large recruitment 
may lead to less stringency, contaminating the pheno-
typic pattern with inappropriate clinical backgrounds, 
which may lead to spurious associations. The power 
of our case-control study was acceptable (72.85, 73.95, 
51.19% for the three positive associations obtained, 
respectively), and frequencies of SNPs in our control 
population were close to those in Caucasian popula-
tions [21], which attests to the reliability of the study.
The present investigation was able to detect associa-
tion of insulin gene VNTR with metabolic components 
in PCOS, but it was not able to highlight any consistent 
advantage for using haplotypes instead of SNPs taken 
alone. This needs to be deepened by extending the 
explored region upstream and downstream through 
the screening of much more SNPs. This may allow us to 
observe that haplotypes carry more genetic information 
than SNPs taken alone. It is expected to carry out future 
studies in the context of the European Project MEDI-
GENE FP7 (FP7-279171-1) with deeper screening of 
the 50 kb locus involving VNTR of insulin gene, IGF-2, 
and TH genes for a better understanding of the relation 
between the locus and complex metabolic disorders. 
Indeed, we believe that genes reported as not associated 
with metabolic complex disorders by GWAS studies (as 
insulin gene VNTR) even though they were previously 
associated using the candidate gene approach is due to 
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a lack of genome characterisation by GWAS. Using hun-
dred of thousands of SNPs (six KSNPs to about a million 
SNPs) for screening the whole genome is not enough, 
knowing the existence of at least 27 million SNPs and 
rare variants with potential effects. One could also criti-
cise our study since we focused on the insulin secretion 
component without taking into account potential genes 
such as TCF7L2 (MIM: 602228). It is expected in future 
that genotyping, in our population, of other potential 
genes with a role in insulin secretion, notably TCF7L2 
and study the interaction of the insulin gene locus with 
this panel of genes will take place.
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